Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-19

Clinical Trial Update: G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update investigates whether administering granulocyte colony-stimulating factor (filgrastim) during IVF improves endometrial receptivity and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neupogen (Filgrastim)
  • ZARXIO (FILGRASTIM-SNDZ)

Snippet

Sponsor: Istishari Arab Hospital | Conditions: Women Infertility | Phase 2, Phase 3 | Status: UNKNOWN